Skip to main content

Table 4 Factors associated with receiving inappropriate high doses

From: Pattern, frequency and factors associated with inappropriate high dosing in chronic kidney disease patients at a tertiary care hospital in Pakistan

Variables

Inappropriate high dose

Frequency (%)

Univariate analysis

Multivariate analysis

OR (95%CI)

p-value

OR (95%CI)

p-value

Gender

     

Male

96 (56.1)

Referent

   

Female

66 (50.1)

0.78 (0.49–1.23)

0.288

-

-

Age (years)

     

≤ 40

9 (14.3)

Referent

   

41–60

105 (61.4)

9.54 (4.42–20.61)

< 0.001

5.76 (2.46–13.50)

< 0.001

> 60

48 (69.6)

13.71 (5.73–32.81)

< 0.001

9.49 (2.87–21.56)

< 0.001

Weight (kilogram)

     

41–60

6 (22.2)

Referent

   

61–80

60 (55.6)

4.37 (1.64–11.70)

0.003

2.75 (0.84–8.93)

0.093

> 80

96 (57.1)

4.67 (1.79–12.16)

0.002

2.82 (0.87–9.12)

0.083

CKD stage

     

3

6 (40.0)

Referent

   

4

45 (42.9)

1.12 (0.37–3.39)

0.834

0.37 (0.07–1.89)

0.230

5

111 (60.7)

2.31 (0.79–6.77)

0.126

1.24 (0.26–5.96)

0.790

Hypertension

     

No

18 (37.5)

Referent

   

Yes

144 (56.5)

2.16 (1.15–4.08)

0.017

2.68 (1.24–5.80)

0.012

Anemia

     

No

24 (36.4)

Referent

   

Yes

138 (58.2)

2.44 (1.39–4.29)

0.002

1.90 (0.95–3.78)

0.067

Diabetes mellitus

     

No

63 (36.8)

Referent

   

Yes

99 (75.0)

5.14 (3.11–8.49)

< 0.001

3.47 (1.91–6.32)

< 0.001

Cardiovascular disease

     

No

108 (48.0)

Referent

   

Yes

54 (96.2)

2.44 (1.41–4.21)

0.001

2.82 (1.40–5.67)

0.004

Other comorbidities

     

No

156(54.2)

Referent

   

Yes

6 (40.0)

0.56 (0.20–1.63)

0.289

-

-

  1. CI, confidence interval; CKD, chronic kidney disease; OR, odds ratio